AGGRESSIVE VARIANT PROSTATE CARCINOMA
Clinical trials for AGGRESSIVE VARIANT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE VARIANT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for AGGRESSIVE VARIANT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to tame tough prostate cancer
Disease control OngoingThis phase 2 trial tests a multi-drug approach for men with aggressive variant prostate cancer that has spread. First, patients receive chemotherapy (cabazitaxel and carboplatin) plus an immunotherapy (cetrelimab). Then, they are randomly assigned to take either a PARP inhibitor …
Matched conditions: AGGRESSIVE VARIANT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug duo takes on tough cancers
Disease control OngoingThis early-stage trial tests a new drug (DS3201) combined with an immunotherapy (ipilimumab) in people whose prostate, bladder, or kidney cancer has spread. The main goals are to find the safest dose and see what side effects occur. About 65 participants will receive both drugs t…
Matched conditions: AGGRESSIVE VARIANT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC